Publications scientifiques Bordet Publications scientifiques Bordet Rechercher… Année de publication - Any -20242025 Management of high-grade neuroendocrine neoplasms: impact of functional imaging. Auteurs Islam O, Sarti K, Verbruggen L, Vandermissen V, Vanden Bulcke K, Annys L, Verslype C, Van Laethem JL, Kalantari HR, Janssens J, Hendlisz A, Cuyle PJ, Demolin G, Decaestecker J, Geboes K, Coche JL, Van Ongeval J, Lybaert W, Peeters M, Borbath I, Vandamme T Auteurs (entité) HENDLISZ ALAIN Revue Endocr Relat Cancer Date de publication 2025-01 Management of high-grade neuroendocrine neoplasms: impact of functional imaging. Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial. Auteurs Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano de Colella JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hébraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Cherel B, Frenzel L, Vekemans MM, Bigot N, Avet-Loiseau H, Corre J, Moreau P Auteurs (entité) MEULEMAN NATHALIE Revue Blood Date de publication 2025-01 Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial. Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) LANGOUO FONTSA MIREILLE Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) MOUNA Oumnia Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) MEYERS MICHEL Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) MEYERS MICHEL Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) LANGOUO FONTSA MIREILLE Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) MOUNA Oumnia Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Macroscopic Hematuria Revealing Bladder Myeloid Sarcoma in Acute Myeloid Leukemia. Auteurs Halloumi O, Sebastian W, Harb M, Trépant AL, Andreozzi F Auteurs (entité) ANDREOZZI FABIO Revue Cureus Date de publication 2024-12 Macroscopic Hematuria Revealing Bladder Myeloid Sarcoma in Acute Myeloid Leukemia. Charger plus Hôpital Erasme Consultez toutes les publications scientifiques d'Erasmus Publications scientifiques d'Erasmus Hôpital pédiatrique Reine Fabiola Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola Publications scientifiques de l'Hôpital pour enfants Reine Fabiola Institut Jules Bordet Consultez toutes les publications scientifiques de Jules Bordet Publications scientifiques de Jules Bordet
Management of high-grade neuroendocrine neoplasms: impact of functional imaging. Auteurs Islam O, Sarti K, Verbruggen L, Vandermissen V, Vanden Bulcke K, Annys L, Verslype C, Van Laethem JL, Kalantari HR, Janssens J, Hendlisz A, Cuyle PJ, Demolin G, Decaestecker J, Geboes K, Coche JL, Van Ongeval J, Lybaert W, Peeters M, Borbath I, Vandamme T Auteurs (entité) HENDLISZ ALAIN Revue Endocr Relat Cancer Date de publication 2025-01 Management of high-grade neuroendocrine neoplasms: impact of functional imaging.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial. Auteurs Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano de Colella JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hébraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Cherel B, Frenzel L, Vekemans MM, Bigot N, Avet-Loiseau H, Corre J, Moreau P Auteurs (entité) MEULEMAN NATHALIE Revue Blood Date de publication 2025-01 Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial.
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) LANGOUO FONTSA MIREILLE Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) MOUNA Oumnia Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Auteurs Mouna O, Hanssens C, Meyers M, Langouo M Auteurs (entité) MEYERS MICHEL Revue Curr Opin Oncol Date de publication 2025-01 Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) MEYERS MICHEL Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) LANGOUO FONTSA MIREILLE Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Auteurs Meyers M, Mouna O, Langouo M Auteurs (entité) MOUNA Oumnia Revue Curr Opin Oncol Date de publication 2024-12 Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
Macroscopic Hematuria Revealing Bladder Myeloid Sarcoma in Acute Myeloid Leukemia. Auteurs Halloumi O, Sebastian W, Harb M, Trépant AL, Andreozzi F Auteurs (entité) ANDREOZZI FABIO Revue Cureus Date de publication 2024-12 Macroscopic Hematuria Revealing Bladder Myeloid Sarcoma in Acute Myeloid Leukemia.
Hôpital Erasme Consultez toutes les publications scientifiques d'Erasmus Publications scientifiques d'Erasmus
Hôpital pédiatrique Reine Fabiola Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola Publications scientifiques de l'Hôpital pour enfants Reine Fabiola
Institut Jules Bordet Consultez toutes les publications scientifiques de Jules Bordet Publications scientifiques de Jules Bordet
